Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.0.0 - STU1 United States of America flag

Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions

: Specification Type Terminology - JSON Representation

Draft as of 2024-10-30

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "pqcmc-specification-type-terminology",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet pqcmc-specification-type-terminology</b></p><a name=\"pqcmc-specification-type-terminology\"> </a><a name=\"hcpqcmc-specification-type-terminology\"> </a><a name=\"pqcmc-specification-type-terminology-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-cmc-ncit-dummy.html\"><code>http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C134021\">C134021</a></td><td>Drug Product</td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C134022\">C134022</a></td><td>Drug Substance</td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C133931\">C133931</a></td><td>Raw Materials/Excipients/Intermediates/Reagents</td></tr></table></li></ul></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "brr"
    }
  ],
  "url" : "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-specification-type-terminology",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.4.642.40.36.48.24"
    }
  ],
  "version" : "1.0.0",
  "name" : "PqcmcSpecificationTypeTerminology",
  "title" : "Specification Type Terminology",
  "status" : "draft",
  "experimental" : false,
  "date" : "2024-10-30T15:40:50+00:00",
  "publisher" : "HL7 International / Biomedical Research and Regulation",
  "contact" : [
    {
      "name" : "HL7 International / Biomedical Research and Regulation",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/rcrim"
        },
        {
          "system" : "email",
          "value" : "brr@lists.HL7.org"
        }
      ]
    }
  ],
  "description" : "Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US",
          "display" : "United States of America"
        }
      ]
    }
  ],
  "compose" : {
    "include" : [
      {
        "system" : "http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy",
        "concept" : [
          {
            "code" : "C134021",
            "display" : "Drug Product"
          },
          {
            "code" : "C134022",
            "display" : "Drug Substance"
          },
          {
            "code" : "C133931",
            "display" : "Raw Materials/Excipients/Intermediates/Reagents"
          }
        ]
      }
    ]
  }
}